450 related articles for article (PubMed ID: 12767733)
21. Topiramate for alcohol dependence.
Olmsted CL; Kockler DR
Ann Pharmacother; 2008 Oct; 42(10):1475-80. PubMed ID: 18698008
[TBL] [Abstract][Full Text] [Related]
22. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence.
Anton RF; Kranzler H; Breder C; Marcus RN; Carson WH; Han J
J Clin Psychopharmacol; 2008 Feb; 28(1):5-12. PubMed ID: 18204334
[TBL] [Abstract][Full Text] [Related]
23. Modulation of impulsivity by topiramate: implications for the treatment of alcohol dependence.
Rubio G; Martínez-Gras I; Manzanares J
J Clin Psychopharmacol; 2009 Dec; 29(6):584-9. PubMed ID: 19910725
[TBL] [Abstract][Full Text] [Related]
24. A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence.
Simpson TL; Saxon AJ; Meredith CW; Malte CA; McBride B; Ferguson LC; Gross CA; Hart KL; Raskind M
Alcohol Clin Exp Res; 2009 Feb; 33(2):255-63. PubMed ID: 18945226
[TBL] [Abstract][Full Text] [Related]
25. Topiramate in the treatment of alcohol dependence: a meta-analysis.
Arbaizar B; Diersen-Sotos T; Gómez-Acebo I; Llorca J
Actas Esp Psiquiatr; 2010; 38(1):8-12. PubMed ID: 20931405
[TBL] [Abstract][Full Text] [Related]
26. Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.
O'Malley SS; Corbin WR; Leeman RF; DeMartini KS; Fucito LM; Ikomi J; Romano DM; Wu R; Toll BA; Sher KJ; Gueorguieva R; Kranzler HR
J Clin Psychiatry; 2015 Feb; 76(2):e207-13. PubMed ID: 25742208
[TBL] [Abstract][Full Text] [Related]
27. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
Wilding J; Van Gaal L; Rissanen A; Vercruysse F; Fitchet M;
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1399-410. PubMed ID: 15486569
[TBL] [Abstract][Full Text] [Related]
28. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
[TBL] [Abstract][Full Text] [Related]
29. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
30. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial.
Gadde KM; Allison DB; Ryan DH; Peterson CA; Troupin B; Schwiers ML; Day WW
Lancet; 2011 Apr; 377(9774):1341-52. PubMed ID: 21481449
[TBL] [Abstract][Full Text] [Related]
31. Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men.
Isgro M; Doran N; Heffner JL; Wong E; Dinh E; Tibbs J; Russell K; Bittner T; Wehrle C; Worley MJ; Anthenelli RM
J Stud Alcohol Drugs; 2017 Mar; 78(2):232-240. PubMed ID: 28317503
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.
O'Malley SS; Garbutt JC; Gastfriend DR; Dong Q; Kranzler HR
J Clin Psychopharmacol; 2007 Oct; 27(5):507-12. PubMed ID: 17873686
[TBL] [Abstract][Full Text] [Related]
33. Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders.
Knapp CM; Ciraulo DA; Sarid-Segal O; Richardson MA; Devine E; Streeter CC; Oscar-Berman M; Surprise C; Colaneri L; Putnam M; Waters M; Richambault C
J Clin Psychopharmacol; 2015 Feb; 35(1):34-42. PubMed ID: 25427171
[TBL] [Abstract][Full Text] [Related]
34. Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.
Kranzler HR; Covault J; Feinn R; Armeli S; Tennen H; Arias AJ; Gelernter J; Pond T; Oncken C; Kampman KM
Am J Psychiatry; 2014 Apr; 171(4):445-52. PubMed ID: 24525690
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
36. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial.
Johnson BA; Roache JD; Javors MA; DiClemente CC; Cloninger CR; Prihoda TJ; Bordnick PS; Ait-Daoud N; Hensler J
JAMA; 2000 Aug 23-30; 284(8):963-71. PubMed ID: 10944641
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of the glycine transporter-1 inhibitor org 25935 for the prevention of relapse in alcohol-dependent patients: a randomized, double-blind, placebo-controlled trial.
de Bejczy A; Nations KR; Szegedi A; Schoemaker J; Ruwe F; Söderpalm B
Alcohol Clin Exp Res; 2014 Sep; 38(9):2427-35. PubMed ID: 25257291
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of topiramate in the treatment of crack cocaine dependence: a double-blind, randomized, placebo-controlled trial.
Baldaçara L; Cogo-Moreira H; Parreira BL; Diniz TA; Milhomem JJ; Fernandes CC; Lacerda AL
J Clin Psychiatry; 2016 Mar; 77(3):398-406. PubMed ID: 27046312
[TBL] [Abstract][Full Text] [Related]
39. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.
Mann K; Bladström A; Torup L; Gual A; van den Brink W
Biol Psychiatry; 2013 Apr; 73(8):706-13. PubMed ID: 23237314
[TBL] [Abstract][Full Text] [Related]
40. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial.
Guardia J; Caso C; Arias F; Gual A; Sanahuja J; Ramírez M; Mengual I; Gonzalvo B; Segura L; Trujols J; Casas M
Alcohol Clin Exp Res; 2002 Sep; 26(9):1381-7. PubMed ID: 12351933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
